MCID: DBT032
MIFTS: 20

Diabetes Mellitus, Insulin-Dependent, 22 malady

Categories: Genetic diseases, Rare diseases, Endocrine diseases, Metabolic diseases

Aliases & Classifications for Diabetes Mellitus, Insulin-Dependent, 22

About this section

Aliases & Descriptions for Diabetes Mellitus, Insulin-Dependent, 22:

Name: Diabetes Mellitus, Insulin-Dependent, 22 52 70 27 12 68
 
Iddm22 70

Classifications:



External Ids:

OMIM52 612522
MedGen37 C2675864
MeSH39 D003922

Summaries for Diabetes Mellitus, Insulin-Dependent, 22

About this section
UniProtKB/Swiss-Prot:70 Diabetes mellitus, insulin-dependent, 22: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.

MalaCards based summary: Diabetes Mellitus, Insulin-Dependent, 22, is also known as iddm22 An important gene associated with Diabetes Mellitus, Insulin-Dependent, 22 is CCR5 (C-C Motif Chemokine Receptor 5 (Gene/Pseudogene)). Affiliated tissues include testes, pancreas and kidney.

Description from OMIM:52 612522

Symptoms & Phenotypes for Diabetes Mellitus, Insulin-Dependent, 22

About this section


Clinical features from OMIM:

612522

Drugs & Therapeutics for Diabetes Mellitus, Insulin-Dependent, 22

About this section

Drugs for Diabetes Mellitus, Insulin-Dependent, 22 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 49)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
ZincapprovedPhase 4, Phase 3, Phase 2, Phase 122317440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
2
rituximabapprovedPhase 41654174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
3
PancrelipaseapprovedPhase 4, Phase 2, Phase 1, Early Phase 193553608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
4insulinPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 14524
5IncretinsPhase 4, Phase 3, Phase 2, Phase 11537
6Insulin, Globin ZincPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 14523
7pancreatinPhase 4, Phase 2, Phase 1, Early Phase 1935
8AntibodiesPhase 46045
9AutoantibodiesPhase 4126
10Hypoglycemic AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 15733
11Antibodies, MonoclonalPhase 43795
12Antirheumatic AgentsPhase 410627
13HormonesPhase 4, Phase 3, Phase 2, Phase 113979
14ImmunoglobulinsPhase 46045
15gastric inhibitory polypeptidePhase 479
16Glucagon-Like Peptide 1Phase 4, Phase 3, Phase 2, Phase 1694
17glucagonPhase 4, Phase 3, Phase 2, Phase 1462
18Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 112767
19Pharmaceutical SolutionsPhase 4, Phase 2, Phase 17793
20Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 112778
21Gastrointestinal AgentsPhase 4, Phase 2, Phase 1, Early Phase 18109
22
Hydrocortisoneapproved, vet_approvedPhase 364050-23-75754, 657311
Synonyms:
(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
11-Hydrocortisone
11-beta-Hydrocortisone
11-beta-Hydroxycortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b-Hydrocortisone
11b-Hydroxycortisone
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11beta-Hydroxycortisone
11beta-hydrocortisone
11β-hydrocortisone
17-Hydroxycorticosterone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
2v95
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
AI3-25006
AKOS001582651
Acticort
Acticort (TN)
Aeroseb HC
Aeroseb-HC
Ala-Cort
Ala-Scalp
Alacort
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Aquacort
Aquanil HC
B48448A1-24BA-47CA-8D9E-43E5BC949386
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
Balneol-hc
Barseb HC
Basan-Corti
Beta-hc
Bio-0648
C00735
C21H30O5
CCRIS 5854
CHEBI:17650
CHEMBL389621
CID5754
COR-OTICIN
CPD000653523
CaldeCORT Spray
Cetacort
Chronocort
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
Compound F
Compound F (kendall)
Cor-Tar-Quin
Corhydron
Cort-Dome
Cort-Quin
Cortanal
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisporin
Cortisporin Otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cortril
Cremesone
Cremicort-H
Cutisol
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Derm-Aid
Dermacort
Dermaspray
Dermil
Dermocortal
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
DuoCort
EINECS 200-020-1
EU-0100594
Ef corlin
Efcorbin
Efcortelan
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
Evacort
Ficortril
Fiocortril
Flexicort
Foille Insetti
Genacort
Genacort (lotion)
Glycort
Gyno-Cortisone
H 4001
H-Cort
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
H4001_SIGMA
H6909_SIGMA
HC
HC #1
 
HC #4
HC (HYDROCORTISONE)
HMS1569I16
HMS2090M04
HSDB 3339
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE IN ABSORBASE
Heb Cort
Heb-Cort
Hi-cor
Hidalone
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
Hydro-Adreson
Hydro-Colisona
Hydro-RX
Hydro-colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone Acetate
Hydrocortisone Base
Hydrocortisone Butyrate
Hydrocortisone Sodium Phosphate
Hydrocortisone Valerate
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone free alcohol
Hydrocortisone solution
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Kendall'S compound F
Kendall's compound F
Komed HC
Kyypakkaus
LMST02030001
LS-7439
Lacticare HC
Lacticare-HC
Lactisona
Lopac0_000594
Lubricort
MLS000069609
MLS001148103
MLS002207135
MLS002222189
Maintasone
Medicort
Meusicort
Mildison
Milliderm
MolPort-001-794-637
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
NSC 10483
NSC-10483
NSC10483
Neo-Cort-Dome
Neo-Cortef
Neosporin-H Ear
Nogenic HC
Nutracort
Nystaform-HC
ORLEX HC
Optef
Otalgine
Otic-Neo-Cort-Dome
Otobiotic
Otocort
Otosone-F
Pediotic Suspension
Penecort
Permicort
Polcort H
Preparation H Hydrocortisone Cream
Prepcort
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prestwick_265
Prevex HC
Proctocort
Proctofoam
Proctozone HC
Protocort
Racet
Rectasol-HC
Rectoid
Reichstein'S substance M
Reichstein's substance M
Remederm HC
S1696_Selleck
SAM002264617
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Sanatison
Scalp-Cort
Scalpicin Capilar
Schericur
Scheroson F
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral Hydrocort
Tarcortin
Texacort
Texacort lotion 25
Timocort
Topicort
Transderma H
Traumaide
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Uniderm
Vioform-Hydrocortisone
VoSol HC
Vytone
Zenoxone
[3H]cortisol
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
hydrocortisone
23
Insulin AspartapprovedPhase 3, Phase 2442116094-23-616132418
Synonyms:
(AspB28)-human insulin
1024611-56-0
116094-23-6
139532-40-4
28(sup B)-L-Aspartic acid-insulin (human)
877034-90-7
AspB28-insulin (human)
Aspart
Aspart Insulin
Aspart insulin
B28-Asp-insulin
B28-Aspart-Insulin
INA-X 14
 
INA-X14
Insulin X14
Insulin aspart
Insulin aspart [USAN]
Insulin aspart protamine recombinant
Insulin aspart recombinant
Insulin, Asp(B28)
LS-185932
NovoLog
NovoMix 30
NovoRapid
NovoRapid 30 Mix
Novolog mix 70/30
UNII-D933668QVX
24
LiraglutideapprovedPhase 3, Phase 1315204656-20-2
Synonyms:
204656-20-2
Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
C439759
Liraglutida
Liraglutida [INN-Spanish]
Liraglutide
Liraglutide [USAN:INN]
Liraglutide recombinant
Liraglutidum
Liraglutidum [INN-Latin]
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide
 
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
NN 2211
NN-2211
NN2211
NNC 90-1170
N²⁶-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide
N²⁶-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide
UNII-839I73S42A
Victoza
nn 2211
nn2211
victoza
25
Insulin GlargineapprovedPhase 3, Phase 1522160337-95-1
Synonyms:
 
Insulin Glargine (rDNA origin)
Insulin glargine recombinant
26
Insulin DetemirapprovedPhase 3196169148-63-45311023
Synonyms:
Detemir
 
Insulin detemir recombinant
Insulin,detemir,human
27Isophane Insulin, HumanPhase 3151
28Insulin, IsophanePhase 3252
29Isophane insulin, beefPhase 3151
30Hydrocortisone acetatePhase 3640
31ProtaminesPhase 3179
32Biphasic InsulinsPhase 3155
33Hydrocortisone 17-butyrate 21-propionatePhase 3640
34Insulin, Long-ActingPhase 3358
35Insulin degludec, insulin aspart drug combinationPhase 3248
36Cortisol succinatePhase 3640
37
Doxycyclineapproved, investigational, vet_approvedPhase 2237564-25-054671203
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
5-hydroxy-α-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6alpha-deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Alti-Doxycycline
Anhydrous doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline (200mg/day) or Placebo
 
Doxycycline (INN)
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
38
Insulin LisproapprovedPhase 2235133107-64-9
Synonyms:
Insulin lispro (genetical recombination)
Insulin lispro (rDNA origin)
Insulin lispro protamine
 
Insulin lispro protamine recombinant
Insulin lispro recombinant
Insulin,lispro,human/rDNA
Insulin,lispro,protamine/rDNA
39Antiparasitic AgentsPhase 22127
40Antiprotozoal AgentsPhase 21986
41Anti-Bacterial AgentsPhase 210884
42Anti-Infective AgentsPhase 221402
43AntimalarialsPhase 21216
44
Pramlintideapproved, investigationalPhase 143151126-32-8
Synonyms:
151126-32-8
187887-46-3
196078-30-5
AC 0137
AC0137
L-Tyrosinamide, L-lysyl-L-cysteinyl-L-asparaginyl-L-threonyl-L-alanyl-L-threonyl-L-cysteinyl-L-alanyl-L-threonyl-L-glutaminyl-L-arginyl-L-leucyl-L-alanyl-L-asparaginyl-L-phenylalanyl-L-leucyl-L-valyl-L-histidyl-L-seryl-L-seryl-L-asparaginyl-L-asparaginyl-L-phenylalanylglycyl-L-prolyl-L-isoleucyl-L-leucyl-L-prolyl-L-prolyl-L-threonyl-L-asparaginyl-L-valylglycyl-L-seryl-L-asparaginyl-L-threonyl-, cyclic (2-7)-disulfide
LS-181996
LS-188084
 
Pramlintide
Pramlintide [USAN]
Pramlintide acetate
Pramlintide acetate [USAN]
Pramlintide acetate hydrate
Symlin
Triproamylin
UNII-726I6TE06G
UNII-D3FM8FA78T
45
Exenatideapproved, investigationalPhase 1289141758-74-915991534
Synonyms:
141732-76-5
141758-74-9
286014-72-0
335149-21-8
AC 2993
AC 2993 LAR
AC 2993A
AC-2993
AC002993
AC2993
AC2993a
Bydureon
Byetta
 
C074031
CHEBI:490990
CHEMBL414357
Ex4 peptide
Exenatide
Exenatide Synthetic
Exenatide synthetic
Exendin 4
Exendin 4 (Heloderma suspectum)
Exendin-4
Extendin-4
LY2148568
Synthetic exendin-4
UNII-9P1872D4OL
46Liver Extracts3868
47tyrosineNutraceutical659
48TomatoNutraceutical52
49TeaNutraceutical317

Interventional clinical trials:

(show all 38)
idNameStatusNCT IDPhase
1Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 DiabetesUnknown statusNCT01280682Phase 4
2Mixed Meal Test in Type 1 Diabetes on Insulin Pump Therapy: Optimization of Artificial PancreasUnknown statusNCT02003274Phase 4
3Improving Blood Pressure Management in Patients With DiabetesCompletedNCT00374270Phase 4
4Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 DiabetesActive, not recruitingNCT02232971Phase 4
5Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human InsulinUnknown statusNCT00668850Phase 3
6A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human InsulinCompletedNCT00888732Phase 3
7Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn PhenomenonCompletedNCT00694122Phase 3
8The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 DiabetesCompletedNCT02098395Phase 3
9Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes MellitusCompletedNCT01709929Phase 3
10Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT01074268Phase 3
11Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a HypoglycaemiaCompletedNCT02028078Phase 2
12Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes CampCompletedNCT02189694Phase 2
13Evaluation of Doxycyline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic RetinopathyCompletedNCT00511875Phase 2
14Comparison of an Artificial Pancreas Versus Threshold Low Glucose Suspend in Type 1 Diabetic ChildrenRecruitingNCT02509429Phase 2
15Home Testing of Day and Night Closed Loop With Pump Suspend FeatureRecruitingNCT02523131Phase 2
16An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets Within the Bioartificial Pancreas Beta-Air in Patients With Type 1 Diabetes MellitusActive, not recruitingNCT02064309Phase 1, Phase 2
17Safety and Efficacy of Arterial Delivery of Autologous Bone Marrow Cells in the Treatment of Insulin-Dependent DiabetesWithdrawnNCT00971503Phase 2
18Closed Loop System With Pramlintide Versus ExenatideCompletedNCT01269008Phase 1
19The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 DiabetesCompletedNCT01536665Phase 1
20Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon DosagesCompletedNCT01916265Phase 1
21A Study of LY2605541 Versus Insulin Glargine on Blood SugarCompletedNCT01654380Phase 1
22Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With DiabetesRecruitingNCT02745808Phase 1
23Study of PTPN22 C1858T Polymorphism in Children and Adolescents of Greek Origin With T1DMCompletedNCT01276743
24Impact of c242T Polymorphism of p22phox in Diabetic type1 NephropathyCompletedNCT01371955
25Effects of Low Intensity Aerobic Exercise on the Microvascular Endothelial Function of Patients With Type 1 DiabetesCompletedNCT02441504
26Outpatient Control-to-Range: System and Monitoring TestingCompletedNCT01697150
27Controlled Insulin Delivery: Combining Technology With TreatmentCompletedNCT01484457Early Phase 1
28Severe Hypoglycemia in Pregnant Women With Type 1 DiabetesCompletedNCT00435565
29Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - PadovaCompletedNCT01447992Early Phase 1
30Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - MontpellierCompletedNCT01447979Early Phase 1
31Safety Study of Repeated Doses of Glucagon on Animal Starch in the LiverCompletedNCT01986231
32Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (Italy)CompletedNCT01727817
33Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (France)CompletedNCT01742741
34Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System EfficacyCompletedNCT01714505
35Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)RecruitingNCT02671968
36Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 DiabetesRecruitingNCT02107326
37T1D Risk Assessment in Kids With RelativesRecruitingNCT02184676
38Comparison of Two Protocols on the Implementation of a Fasting Day in Type 1 DiabetesActive, not recruitingNCT02667769

Search NIH Clinical Center for Diabetes Mellitus, Insulin-Dependent, 22

Genetic Tests for Diabetes Mellitus, Insulin-Dependent, 22

About this section

Genetic tests related to Diabetes Mellitus, Insulin-Dependent, 22:

id Genetic test Affiliating Genes
1 Diabetes Mellitus, Insulin-Dependent, 2227

Anatomical Context for Diabetes Mellitus, Insulin-Dependent, 22

About this section

MalaCards organs/tissues related to Diabetes Mellitus, Insulin-Dependent, 22:

36
Testes, Pancreas, Kidney, Eye, Liver, Endothelial, Bone

Publications for Diabetes Mellitus, Insulin-Dependent, 22

About this section

Variations for Diabetes Mellitus, Insulin-Dependent, 22

About this section

Expression for genes affiliated with Diabetes Mellitus, Insulin-Dependent, 22

About this section
Search GEO for disease gene expression data for Diabetes Mellitus, Insulin-Dependent, 22.

Pathways for genes affiliated with Diabetes Mellitus, Insulin-Dependent, 22

About this section

GO Terms for genes affiliated with Diabetes Mellitus, Insulin-Dependent, 22

About this section

Sources for Diabetes Mellitus, Insulin-Dependent, 22

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet